New approaches in the treatment of Ulcerative Colitis

A tétel rövid nézete
dc.contributor.advisorPórszász, Róbert
dc.contributor.advisordeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.authorSaid, Majeid
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentDrimba, László
dc.contributor.opponentMegyeri, Attila
dc.contributor.opponentdeptKenézy Kórház Központi Aneszteziológiai és Intezív Terápiás Osztályhu_HU
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.date.accessioned2021-08-18T11:32:16Z
dc.date.available2021-08-18T11:32:16Z
dc.date.created2021
dc.description.abstractInflammatory bowel disease (IBD) considered to be a chronic disease affecting the gastrointestinal (GI) tract. It is divided to 2 major groups: ULCERATIVE COLITIS (UC) and CROHN’S DISEASE. The treatment of ULCERATIVE COLITIS is complicated and patient specific. Due to the very fact that ULCERATIVE COLITIS can negatively have many aspects on the patient’s quality of life, and it's related to high risk of complications or maybe mortality, there are developed wide selection of treatments which makes it very challenging in our clinical practice nowadays. because of different approaches and newly developed drugs which will be utilized in several formulations, patients affected by ULCERATIVE COLITIS are often managed and controlled better.hu_HU
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent35hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/321300
dc.language.isoenhu_HU
dc.subjectUC treatmentshu_HU
dc.subjectUC treatmentshu_HU
dc.subject.dspaceDEENK Témalista::Orvostudományhu_HU
dc.titleNew approaches in the treatment of Ulcerative Colitishu_HU
Fájlok
Gyűjtemények
Theses (Faculty of Medicine)